Sa1270 Can We Increase the Dose Interval of Infliximab to...

Gastroenterology 2014 / 05 Vol. 146; Iss. 5

Sa1270 Can We Increase the Dose Interval of Infliximab to 10 Weeks Without Risking Loss of Response in Patients With Crohn's Disease? Prospective, Single-Center Pilot Study Based on Successive Measurements of Fecal Calprotectin

Mantzaris, Gerassimos J., Karatzas, Pantelis, Kyriakos, Nikolaos, Archavlis, Emmanuel J., Papamichael, Konstantinos, Tzannetakou, Xanthippi, Internos, Iosif, Anastasiadis, Stelios, Tsironikos, Dimitri
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
146
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(14)60874-X
Date:
May, 2014
File:
PDF, 50 KB
english, 2014
Conversion to is in progress
Conversion to is failed